{"id":"isophane-human-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL2108973","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Isophane insulin (NPH insulin) is a suspension of insulin crystals complexed with protamine, which slows absorption compared to regular insulin, providing intermediate duration of action (10-18 hours). It mimics the basal insulin secretion pattern of the pancreas and works by binding to insulin receptors on muscle, fat, and liver cells to facilitate glucose transport into cells and promote anabolic metabolism.","oneSentence":"Isophane human insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:20.623Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT06999551","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.","status":"NOT_YET_RECRUITING","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2025-07-01","conditions":"Diabetes Mellitus","enrollment":60},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT05768191","phase":"PHASE4","title":"Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin","status":"COMPLETED","sponsor":"Université NAZI BONI","startDate":"2023-06-15","conditions":"Type 1 Diabetes","enrollment":22},{"nctId":"NCT06619301","phase":"PHASE3","title":"RCT Glargine vs NPH for Treatment of DM in Pregnancy","status":"RECRUITING","sponsor":"Loyola University","startDate":"2024-04-01","conditions":"Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2","enrollment":160},{"nctId":"NCT00383877","phase":"PHASE3","title":"Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":263},{"nctId":"NCT00313742","phase":"PHASE4","title":"The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-04","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":51},{"nctId":"NCT00504673","phase":"PHASE3","title":"Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":277},{"nctId":"NCT00687453","phase":"PHASE4","title":"Insulin Glargine Versus Twice-Daily NPH","status":"TERMINATED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2003-02","conditions":"Type 2 Diabetes Mellitus","enrollment":27},{"nctId":"NCT00521690","phase":"PHASE4","title":"The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":25},{"nctId":"NCT05124457","phase":"PHASE2","title":"DETERMINE: Detemir vs NPH","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-02-01","conditions":"Gestational Diabetes, Diabetes Mellitus, Type 2","enrollment":336},{"nctId":"NCT00506662","phase":"PHASE4","title":"Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT02036372","phase":"NA","title":"Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-01","conditions":"Diabetes Mellitus Type II","enrollment":150},{"nctId":"NCT00788840","phase":"PHASE4","title":"Detemir Energy Expenditure Study","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2008-01","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":30},{"nctId":"NCT01053234","phase":"NA","title":"Different Insulin Regimens and Postprandial Coagulation Activation","status":"COMPLETED","sponsor":"Esbjerg Hospital - University Hospital of Southern Denmark","startDate":"2007-02","conditions":"Type 2 Diabetes, Cardiovascular Risk, Hemostasis","enrollment":78},{"nctId":"NCT05565976","phase":"PHASE2, PHASE3","title":"Dapagliflozin Effect in Cognitive Impairment in Stroke Trial","status":"UNKNOWN","sponsor":"Jaime Daniel Mondragon","startDate":"2020-08-01","conditions":"Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular","enrollment":270},{"nctId":"NCT01963728","phase":"PHASE4","title":"Comparison of Insulin Therapy in Treating Post-Transplant Diabetes","status":"TERMINATED","sponsor":"Inova Health Care Services","startDate":"2013-11-27","conditions":"Diabetes Mellitus","enrollment":2},{"nctId":"NCT05461365","phase":"PHASE3","title":"Intranasal Insulin for COVID-19-related Smell Loss","status":"COMPLETED","sponsor":"Universidad Panamericana","startDate":"2021-01-04","conditions":"Anosmia, Smell Loss, Paraosmia","enrollment":27},{"nctId":"NCT01613807","phase":"PHASE4","title":"Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2008-10","conditions":"Gestational Diabetes Mellitus","enrollment":40},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT02910518","phase":"PHASE1","title":"A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-17","conditions":"Type1 Diabetes Mellitus","enrollment":44},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT03350984","phase":"PHASE4","title":"Insulin Schemes for Type 2 Diabetes Control","status":"COMPLETED","sponsor":"Universidad de Guanajuato","startDate":"2017-11-02","conditions":"Type 2 Diabetes Mellitus","enrollment":75},{"nctId":"NCT03620890","phase":"PHASE4","title":"Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-09-04","conditions":"Diabetes Mellitus, Type 2","enrollment":108},{"nctId":"NCT03389490","phase":"PHASE4","title":"Toujeo Versus NPH Self-titration Study","status":"COMPLETED","sponsor":"Elaine Chow","startDate":"2018-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT04664764","phase":"PHASE4","title":"Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-21","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia, type1diabetes","enrollment":60},{"nctId":"NCT04726657","phase":"NA","title":"Comparison of Two Biphasic Insulin Regimens","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2016-01-18","conditions":"Diabetes Mellitus, Type 2","enrollment":36},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT02486341","phase":"NA","title":"Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-03-31","conditions":"Diabetes","enrollment":30},{"nctId":"NCT03511521","phase":"PHASE4","title":"Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2018-03-27","conditions":"Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes","enrollment":3},{"nctId":"NCT04501250","phase":"NA","title":"Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method","status":"COMPLETED","sponsor":"Geropharm","startDate":"2017-10-23","conditions":"Pharmacokinetics, Bioequivalence","enrollment":52},{"nctId":"NCT02634528","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2016-11-16","conditions":"Diabetes Mellitus","enrollment":85},{"nctId":"NCT01854723","phase":"PHASE4","title":"Comparison Study of Insulin Glargine and NPH Insulin","status":"WITHDRAWN","sponsor":"Providence Health & Services","startDate":"2013-04","conditions":"Diabetes","enrollment":""},{"nctId":"NCT04022291","phase":"PHASE1","title":"Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-15","conditions":"Healthy Volunteer","enrollment":78},{"nctId":"NCT04022304","phase":"PHASE1","title":"Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-15","conditions":"Healthy Volunteer","enrollment":90},{"nctId":"NCT01140438","phase":"NA","title":"Treatment of Latent Autoimmune Diabetes of the Adult","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2009-03","conditions":"Diabetes","enrollment":64},{"nctId":"NCT00564018","phase":"NA","title":"Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-09","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT04023344","phase":"PHASE3","title":"Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Geropharm","startDate":"2018-03-14","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":210},{"nctId":"NCT03959865","phase":"","title":"GLP-1 REceptor Agonists and Real World EvIdeNce","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2018-12-19","conditions":"Type 2 Diabetes","enrollment":6000},{"nctId":"NCT01683331","phase":"PHASE4","title":"A Clinical Trial to Prevent New Onset Diabetes After Transplantation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-08","conditions":"Prevention of New Onset Diabetes Among Kidney Transplant Patients","enrollment":251},{"nctId":"NCT03507829","phase":"PHASE3","title":"Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2012-11-21","conditions":"Hyperglycemia","enrollment":263},{"nctId":"NCT00678080","phase":"NA","title":"Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2008-09","conditions":"Pregnancy Complications","enrollment":25},{"nctId":"NCT00590044","phase":"PHASE4","title":"Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)","status":"COMPLETED","sponsor":"Emory University","startDate":"2007-12","conditions":"Diabetic Ketoacidosis","enrollment":74},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT02033889","phase":"PHASE3","title":"A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-12-13","conditions":"Type 2 Diabetes Mellitus","enrollment":621},{"nctId":"NCT01756105","phase":"PHASE2","title":"Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2012-06","conditions":"Gestational Diabetes, Metformin, Treatment","enrollment":84},{"nctId":"NCT01184014","phase":"PHASE4","title":"Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2010-08","conditions":"Hyperglycemia","enrollment":72},{"nctId":"NCT01680185","phase":"PHASE3","title":"Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2012-08","conditions":"Hyperglycemia","enrollment":85},{"nctId":"NCT02012465","phase":"EARLY_PHASE1","title":"Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-09","conditions":"Lymphoma, Diabetes Mellitus, Type 2, Hyperglycemia","enrollment":15},{"nctId":"NCT01790438","phase":"PHASE3","title":"A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-03","conditions":"Diabetes Mellitus, Type 2","enrollment":641},{"nctId":"NCT01662921","phase":"PHASE2","title":"Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2013-04","conditions":"Diabetes During Pregnancy","enrollment":17},{"nctId":"NCT02451917","phase":"PHASE4","title":"Glargine Versus NPH in Patients With Chronic Kidney Disease","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2013-12","conditions":"Type 2 Diabetes Mellitus, Chronic Kidney Disease","enrollment":34},{"nctId":"NCT03320694","phase":"PHASE3","title":"Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Services Institute of Medical Sciences, Pakistan","startDate":"2016-02-01","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":278},{"nctId":"NCT03320031","phase":"PHASE4","title":"A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy","status":"UNKNOWN","sponsor":"Yanbing Li","startDate":"2017-06-03","conditions":"Type 2 Diabetes Mellitus, Peritoneal Dialysis","enrollment":232},{"nctId":"NCT00574405","phase":"NA","title":"Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2005-04","conditions":"Diabetes Mellitus","enrollment":24},{"nctId":"NCT03220425","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-02-01","conditions":"Diabetes Mellitus, Type 1","enrollment":752},{"nctId":"NCT01589653","phase":"PHASE4","title":"Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-05-26","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":155},{"nctId":"NCT03106870","phase":"NA","title":"Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-06","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":62},{"nctId":"NCT01837680","phase":"NA","title":"Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2013-03","conditions":"Diabetes, Gestational, Diabetes, Type 2","enrollment":105},{"nctId":"NCT00686712","phase":"PHASE4","title":"Insulin Glargine at Bedtime or in AM Versus NPH","status":"COMPLETED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2003-02","conditions":"Type 2 Diabetes Mellitus","enrollment":108},{"nctId":"NCT00835861","phase":"PHASE2","title":"Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-08","conditions":"Non Insulin Dependent Diabetes, Pregnancy","enrollment":31},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT01486966","phase":"PHASE4","title":"Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2011-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":58},{"nctId":"NCT00509925","phase":"PHASE4","title":"Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":23},{"nctId":"NCT00474045","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-05","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":470},{"nctId":"NCT00435019","phase":"PHASE3","title":"Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":348},{"nctId":"NCT00725036","phase":"PHASE3","title":"Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-09-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":305},{"nctId":"NCT01492153","phase":"","title":"NovoLet® Surveillance Study on Using Human Insulin System in Indonesia","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-02-11","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":1981},{"nctId":"NCT00592969","phase":"PHASE4","title":"Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-12-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":164},{"nctId":"NCT00605137","phase":"PHASE3","title":"Safety of Insulin Detemir in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-05-21","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":83},{"nctId":"NCT00595374","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-12-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":114},{"nctId":"NCT00832182","phase":"PHASE3","title":"Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1999-12-22","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":75},{"nctId":"NCT01467141","phase":"PHASE4","title":"Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-06-19","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":26},{"nctId":"NCT01720303","phase":"PHASE4","title":"Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-09-19","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":159},{"nctId":"NCT01562561","phase":"PHASE3","title":"Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-06-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":213},{"nctId":"NCT00799448","phase":"PHASE4","title":"Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2003-09-16","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":40},{"nctId":"NCT01810952","phase":"PHASE4","title":"The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-09","conditions":"Hyperglycemia, Diabetes Mellitus","enrollment":37},{"nctId":"NCT00658099","phase":"","title":"Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":699},{"nctId":"NCT00104182","phase":"PHASE3","title":"Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":503},{"nctId":"NCT00312156","phase":"PHASE3","title":"Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-08","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":347},{"nctId":"NCT01497561","phase":"PHASE1","title":"Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT01486940","phase":"PHASE3","title":"Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-03","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":598},{"nctId":"NCT01542450","phase":"PHASE1","title":"Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-08","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":23},{"nctId":"NCT01497600","phase":"PHASE1","title":"Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT00604253","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":362},{"nctId":"NCT00760448","phase":"PHASE1","title":"Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-04","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":25},{"nctId":"NCT00604344","phase":"PHASE3","title":"Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-04","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":401},{"nctId":"NCT00184665","phase":"PHASE3","title":"Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":501},{"nctId":"NCT01697657","phase":"PHASE3","title":"Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":131},{"nctId":"NCT00604396","phase":"PHASE3","title":"Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":477},{"nctId":"NCT00600626","phase":"PHASE3","title":"Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":394},{"nctId":"NCT01707134","phase":"PHASE3","title":"Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1997-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":753},{"nctId":"NCT00597233","phase":"PHASE4","title":"Human Insulin NPH and Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-10","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":91},{"nctId":"NCT00593255","phase":"PHASE4","title":"Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-07","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":220},{"nctId":"NCT00410033","phase":"NA","title":"Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1989-12","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":74},{"nctId":"NCT00065130","phase":"PHASE3","title":"Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2000-04","conditions":"Diabetes, Gestational Diabetes","enrollment":27},{"nctId":"NCT00715351","phase":"","title":"Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":342}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"CONJOINED TWINS"},{"count":7,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"},{"count":3,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":2,"reaction":"ACUTE KIDNEY INJURY"},{"count":2,"reaction":"ACUTE RESPIRATORY FAILURE"},{"count":2,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":2,"reaction":"CARDIO-RESPIRATORY ARREST"},{"count":2,"reaction":"CONGENITAL BLADDER ANOMALY"},{"count":2,"reaction":"COUGH"},{"count":2,"reaction":"DRUG INTERACTION"}],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"isophane human insulin","genericName":"isophane human insulin","companyName":"Novo Nordisk A/S","companyId":"novo-nordisk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isophane human insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}